HSPO Signs $2B Business Combination with ArcheNova Biotech, Targets Nasdaq Listing
HSPUF is trading near its 52-week low of $10.05 (12% above the low).
Summary
HSPO signed a definitive business combination agreement with ArcheNova Biotech Corp. at a $2.0 billion valuation, targeting a Nasdaq listing with closing expected in Q1 2027.
Key Events · M&A and Partnerships · HSPUF
-
Definitive Business Combination Agreement Signed
On October 12, 2026, HSPO entered into a business combination agreement with ArcheNova Biotech Corp., valuing ArcheNova at $2.0 billion (Company Equity Value).
-
Exchange Ratio and Consideration
ArcheNova shareholders will receive PubCo Ordinary Shares at an exchange ratio of $2.0B divided by $10.00 per share, divided by ArcheNova's outstanding ordinary shares. HSPO shareholders receive one PubCo Ordinary Share per HSPO share.
-
Nasdaq Listing Planned
PubCo Ordinary Shares are expected to be listed on Nasdaq following consummation, with closing targeted for Q1 2027 subject to regulatory and shareholder approvals.
-
Trust Account Balance
As of October 5, 2026, HSPO's trust account held approximately $760,873.03, a modest cash position relative to the $2.0B valuation, implying reliance on target capital or additional financing.
Analysis · HSPUF · Real Estate & Construction
A definitive business combination agreement has been signed with ArcheNova Biotech Corp., a clinical-stage MSC-exosome biopharmaceutical company, at a $2.0 billion enterprise value. This marks the SPAC's long-awaited de-SPAC transaction after a prior business combination was terminated and a going concern warning was issued. The deal would take ArcheNova public on Nasdaq, with closing expected in Q1 2027. The trust account holds only about $760,873, meaning the combined company will rely heavily on the target's own capital and any PIPE financing. For HSPO shareholders, this is a thesis-altering event: the company transforms from a distressed blank-check vehicle into a Nasdaq-listed biotech, though execution risk remains high given the small trust balance, shareholder redemption risk, and the need for regulatory and shareholder approvals.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 52.8% of the 195 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.69%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HSPUF was trading at $11.21 on OTC in the Real Estate & Construction sector, with a market capitalization of approximately $23.6M. The 52-week trading range was $10.05 to $29.70. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.